Q3 2024 Overview
The North American staffing M&A market moderated in Q3 2024, with 24 announced transactions — a 29% decline from Q2’s 35-deal surge. As we anticipated in our Q2 report, Q2’s remarkable 75% quarter-over-quarter jump proved to be an anomaly driven by pent-up demand, not a sustained structural shift. Q3 returned to a more cautious, measured pace consistent with underlying market conditions.
Pre-election uncertainty played a meaningful role in dampening activity. With less than a month remaining before the presidential election, many buyers indicated they were postponing significant strategic decisions, citing potential policy shifts and economic volatility. This hesitancy is a well-documented pattern: markets dislike uncertainty, and M&A is particularly sensitive to it. The race appeared genuinely competitive heading into Q4, amplifying the wait-and-see dynamic.
Geopolitical tensions in the Middle East added to the uncertainty backdrop. More structurally, the broader staffing industry continued to face challenges: revenue and hours worked remained under pressure across commercial and professional segments, making it harder for buyers and sellers to agree on forward valuations.
On a positive note, the Federal Reserve made its long-anticipated pivot in September, cutting its benchmark rate by 50 basis points. With the Fed signaling further cuts over the coming year, the cost of financing acquisitions becomes increasingly attractive — a meaningful tailwind that should help fuel M&A activity heading into 2025 as buyers capitalize on more favorable borrowing conditions.
“Strategic buyers and private equity investors are recognizing the long-term potential of healthcare staffing even as near-term revenue metrics are under pressure. That kind of counter-cyclical conviction is what separates great acquirers from those who only buy at the top.”
Akash Taneja, Founder & Managing Partner, Momentum Advisory PartnersSector Highlights
Other professional staffing — encompassing engineering, finance and accounting, creative, compliance, and adjacent specializations — led Q3 with seven transactions, a notable shift from Q2 when light industrial dominated. Executive search contributed six deals, continuing its steady presence across quarters. IT staffing and consulting accounted for five transactions. Healthcare staffing contributed four deals — a meaningful number given the sector’s ongoing revenue headwinds — reflecting strategic buyer and investor conviction in the long-term structural shortage of clinical talent. Light industrial and commercial staffing was the quietest segment with just two transactions, a sharp reversal from its nine-deal Q2.
Notable Transactions
Q3’s defining transaction was The Vistria Group’s acquisition of Soliant from Olympus Partners for a reported $2.5 billion — one of the largest staffing transactions in years. Soliant is a leading provider of specialized healthcare professionals, including speech pathologists, school psychologists, and nurses, in K-12 and healthcare settings nationwide. The transaction signals significant PE conviction in the structural scarcity of clinical talent over the long term. Cognizant’s $1.3 billion acquisition of Belcan LLC formally closed in Q3 (the definitive agreement was signed in Q2), adding mission-critical digital engineering services across aerospace, defense, and space. Agilus Work Solutions acquired MaxSys Staffing in a Canadian market consolidation that expanded Agilus’s footprint and moved it toward its goal of becoming Canada’s leading recruitment firm.
What This Means for Staffing Founders
- Post-election clarity will unlock pent-up deal flow. The buyers who paused in Q3 citing election uncertainty didn’t disappear — they’re waiting. Once the policy environment becomes clearer, expect a meaningful release of deferred activity. Founders who are ready to go to market in Q4 or Q1 2025 may benefit from this pent-up demand.
- Rate cuts change the math for buyers. A 50-basis-point cut in September and more signaled ahead meaningfully improves deal economics for PE-backed buyers and leveraged acquirers. Lower financing costs translate directly into higher ability to pay — a tailwind for seller valuations in 2025.
- Counter-cyclical buyers are already moving. Healthcare staffing’s revenue is under pressure, yet acquirers completed four healthcare deals in Q3. The $2.5 billion Soliant transaction underscores that sophisticated capital is betting on long-term structural workforce shortages, not near-term EBITDA. For healthcare staffing founders, the buyer universe is deep and conviction is strong.
- Quality scarcity persists despite volume fluctuation. Whether the market is at 35 deals (Q2) or 24 deals (Q3), the consistent theme from active buyers is that high-quality acquisition targets are difficult to find. A well-prepared business coming to market today still competes in a landscape where the right opportunity generates intense buyer interest.